Vaccines for Adults FY26-27

Agency	Centers for Disease Control and Prevention
Deadline	04/07/26
Posted	03/24/26
Estimated Value	Not Provided
Set Aside	None
NAICS	325412 - Pharmaceutical Preparation Manufacturing
PSC	6505 - Drugs And Biologicals
Location	Atlanta, GA 30341 United States

The Centers for Disease Control and Prevention (CDC) contemplates award of one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the purchase of standard commercial adult vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The establishment of these contracts provides opportunity to utilize Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. These funds provide vaccines for state and local health departments to use in populations at greatest risk for under vaccination and disease. The 317 program, as established under Section 317(j) of the Public Health Service Act, works to ensure that adults receive appropriate immunization by partnering with healthcare providers in the public and private sectors. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. The vaccines awarded under these contracts will be purchased for the National Center for Immunization and Respiratory Disease's (NCIRD's) immunization awardees (the fifty state health departments, several large city programs, and current and former U.S. Territories) to support adult immunization programs as provided under Section 317(j) of the Public Health Service Act. In addition, awardees may opt to purchase additional quantities of vaccine for adults under any resulting contract using state and local funds.

Contact name	James Sprigler
Contact email	zbs6@cdc.gov
Contact phone	None
Secondary contact name	Chad Turner
Secondary contact email	ukr9@cdc.gov
Secondary contact phone	None